Online Webinars

Previous Webinars

Nov 21, 2017

Multiplex IHC Immuno-Oncology Panel

Characterization of the immune status of patients becomes increasingly important to personalize cancer treatments. The required extraction of information and biological insights from tissue slides remains challenging because of the broad heterogeneity of tumor and immune cells embedded in the complex tumor microenvironment. Thus, the analysis requires expert insights as...
View Full Event Post
Jun 26, 2017

Imaging-based subtypes of pancreatic cancer

The outcomes of pancreatic cancer have seen little improvement over the past three decades. The disease is associated with a poor prognosis and lack of response to chemotherapy and radiation. To date, there are no reliable ways to separate patients into prognostic groups based on the cancer biology, which would...
View Full Event Post
May 10, 2017

Quantitative Immunohistochemistry for Development of Predictive Biomarkers in Oncology Clinical Trials

In oncology studies, biomarkers have been effectively used to measure tumor progression and to evaluate efficacy of therapies. Increasingly they have been utilized to stratify different patient groups and to develop personalized therapeutic strategies. Towards this goal, immunohistochemistry (IHC) has been playing an increasing role to help understand the mechanism...
View Full Event Post
Mar 21, 2017

Evaluation of the tumor microenvironment using image analysis for clinical trials.

The number of clinical trials examining immunotherapy and combination therapies with immunotherapy as a backbone has exceeded 1000 in 2016. While PD-L1 by immunohistochemistry has been successfully employed as a companion diagnostic for several therapies across a handful of indications, PD-L1 is only one potential biomarker for showing predictive response....
View Full Event Post